Nephrocare Health Services Ltd (NEPHROPLUS) — Board Meeting | 3 September 2026

3 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

ESOP 2026 grant approved for 4,01,362 employees

🔄 What Changed

4,01,362 new options added to ESOP pool

🔮 What's Next

Options vest after one year with 5-year exercise window

💡 Investor Takeaway

This dilutive grant may pressure near-term EPS but aligns employee incentives with long-term growth.

Nephrocare Health Services approved the grant of 4,01,362 employee stock options under its 2026 ESOP scheme on September 3, 2026, with an exercise price of ₹230 per share and a face value of ₹2 per share, subject to vesting conditions and regulatory compliance.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NEPHROPLUS ✨ Ask AI About This

About Nephrocare Health Services Ltd (NEPHROPLUS)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹6,654.6 CrP/E: 77.8ROE: 7.6%ROCE: 14.6%

View full NEPHROPLUS stock details →

📡 Get AI alerts when NEPHROPLUS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEPHROPLUS — Free

💡 Ask AI about this filing

"How will this ESOP dilution affect Q3 EPS?""What is the current share price relative to ₹230 exercise price?""How does this compare to peer ESOP dilution rates?"

Ask AI Free →

📊 More NEPHROPLUS filings

🔴 Insider Trading — 28 September 2026Polar Capital Funds PLC disclosed through its three healthcare-focused funds a 2.535% off-market pur...
Announcement — 25 September 2026Nephrocare Health Services Ltd announced the closure of its trading window effective October 1, 2026...
🔴 Announcement — 22 September 2026Nephrocare Health Services Ltd announced it will attend an investor conference on September 29, 2026...
🔴 Announcement — 18 September 2026Nephrocare Health Services announced that India Ratings upgraded its long-term bank loan facilities ...
🟡 Board Meeting — 18 September 2026Nephrocare Health Services announced on September 18, 2026, that its board approved the rationalisat...

See all NEPHROPLUS filings →

🔥 Also filed on 3 September 2026

517554NHC Foods LtdAnnual Report HINDCOMPOSHindustan Composites LtdAnnouncement 534796JUJHAR LOGISTICS LIMITEDAnnual Report 500388Shree Krishna Paper Mills & Industries LtdAnnual Report VSTLVibhor Steel Tubes LtdInsider Trading GAUDIUMIVFGaudium IVF and Women Health LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NEPHROPLUS files new disclosures

Track NEPHROPLUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.